The tubulointerstitium in progressive diabetic kidney disease: More than an aftermath of glomerular injury?

Kidney International

Volumn 56, Issue 5, 1999, Pages 1627-1637

  Gilbert, Richard E ^a,b   Cooper, Mark E ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b Repatriation Medical Center (Repat Campus)   (Australia)

Author keywords

Extracellular matrix; Interstitium; Transforming growth factor ; Tubule

Indexed keywords

ANGIOTENSIN; TRANSFORMING GROWTH FACTOR BETA;

CYTOKINE PRODUCTION; DIABETES MELLITUS; DIABETIC NEPHROPATHY; FIBRIN FORMATION; HISTOPATHOLOGY; HUMAN; INTERSTITIAL NEPHRITIS; KIDNEY FUNCTION; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

EID: 0032731318     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1999.00721.x     Document Type: Article

References (109)

1. ZIYADEH FN, GOLDFARB S: The renal tubulointerstitium in diabetes mellitus. Kidney Int 39:464-475, 1991
2. ZIYADEH FN: Significance of tubulointerstitial changes in diabetic renal disease. Kidney Int 49(Suppl 54):S10-S13, 1996
3. BORDER WA, YAMAMOTO T, NOBLE NA: Transforming growth factor-ß in diabetic nephropathy. Diabetes Metab Rev 12:309-339, 1996
4. KAISSLING B, LEHIR M: Characterization and distribution of interstitial cell types in the renal cortex of rats. Kidney Int 45:709-720, 1994
5. KAISSLING B, HEGYI I, LOFFING J, LEHIR M: Morphology of interstitial cells in the healthy kidney. Anat Embryol 193:303-318, 1996
6. GROMA V: Demonstration of collagen type VI and alpha-smooth muscle actin in renal flbrotic injury in man. Nephrol Dial Transplant 13:305-312, 1998
7. JOHNSON DV, SAUNDERS HJ, BAXTER RC, FIELD MJ, POLLOCK ÇA: Paracrine stimulation of human renal fibroblasts by proximal tubule cells. Kidney Int 54:747-757, 1998
8. OKADA H, DANOFF TM, KALLURI R, NEILSON EG: Early role of FSP1 in epithelial-mesenchymal transformation. Am J Physiol 42:F563-F574, 1997
9. Wu L, Cox A, ROE C, DZIADEK M, COOPER ME, GILBERT RE: Transforming growth factor ßl and renal injury following subtotal nephrectomy in the rat: Role of the renin-angiotensin system. Kidney Int 51:1553-1567, 1997
10. YANG NS, Wu LL, NIKOLIC-PATERSON DJ, No YY, YANG WC, Mu W, GILBERT RE, COOPER ME, ATKINS RC, LAN HY: Local macrophage and myofibroblast proliferation in progressive renal injury in the rat remnant kidney. Nephrol Dial Transplant 13:1967-1974, 1998
11. NATH K A: The tubulointerstitium in progressive renal disease. Kidney Int 54:992-994, 1998
12. EDDY A: Molecular insights into renal interstitial fibrosis. J Am Soc Nephrol 7:2495-2508, 1996
13. COOPER ME, JERUMS G, GILBERT RE: Diabetic vascular complications. Clin Exp Pharmacol Physiol 24:770-775, 1997
14. COOPER ME: Pathogenesis, prevention and treatment of diabetic nephropathy. Lancet 352:213-219, 1998
15. NATH KA: Tubulointerstitial changes as a major determinant in the progression of renal damage. Am J Kidney Dis 20:1-17,1992
16. BADER R, BADER E, GRUNG KE, MARKENSEN-HAEN S, CHRIST H, BOHLE A: Structure and function of the kidney in diabetic glomerulosclerosis: Correlations between morphological and functional parameters. Pathol Res Pract 167:204-216, 1980
17. LANE PH, STEFFES MW, FIORETTO P, MAUER SM: Renal interstitial expansion in insulin-dependent diabetes mellitus. Kidney Int 43:661-667, 1993
18. MAUER S, STEFFES M, ELLIS E, SUTHERLAND D, BROWN D, GOETZ F: Structural-functional relationships in diabetic nephropathy. J Clin Invest 74:1143-1155, 1984
19. UENO M, KAWASHIMA S, NISHI S, SHIMADA S, SHIMADA N, KARASAWA R, SUZUKI Y, MURUYAMA Y, ARAKAWA M: Tubulointerstitial lesions in non-insulin dependent diabetes mellitus. Kidney Int 52(Suppl 63):S191-S194, 1997
20. TAFT J, NOLAN CI, YEUNG SP, HEWITSON TD, MARTIN FIR: Clinical and histological correlations of decline in renal function in diabetic patients with proteinuria. Diabetes 43:1046-1051, 1994
21. BRITO PL, FIORETTO P, DRUMMOND K, KIM Y, STEFFES MW, BASGEN JM, SissoN-Ross S, MAUER M: Proximal tubular basement membrane width in insulin-dependent diabetes mellitus. Kidney Int 53:754-761, 1998
22. KRIZ W, HOSSER H, HAHNEL B, GRETZ N, PROVOOST AP: From segmental glomerulosclerosis to total nephron degeneration and interstitial fibrosis: A histopathological study in rat models and human glomerulopathies. Nephrol Dial Transplant 13:2781-2798, 1998
23. GANDHI M, OLSON JL, MEYER TW: Contribution of tubular injury to loss of remnant kidney function. Kidney Int 54:1157-1165,1998
24. MARCUSSEN N: Atubular glomeruli and the structural basis for chronic renal failure. Lab Invest 66:265-284, 1992
25. HOSTETTER TH, RENNKE HG, BRENNER BM: The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies. Am J Med 72:375-380, 1982
26. FIORETTO P, STEHOUWER CDA, MAUER M, CHIESURACORONA M, BROCCO E, CARRARO A, BORTOLOSO E, VANHINSBERGH VWM, CREPALDI G, NOSADINI R: Heterogeneous nature of microalbuminuria in NIDDM: Studies of endothelial function and renal structure. Diabetologia 41:233-236, 1998
27. LANE PH, STEFFES MW, MAUER SM: Glomerular structure in IDDM women with low glomerular filtration rate and normal urinary albumin excretion. Diabetes 41:581-586, 1992
28. TSALAMANDRIS C, ALLEN TJ, GILBERT RE, SlNHA A, PANAGIOTO-POULOS S, COOPER ME, JERUMS G: Progressive decline in renal function in diabetic patients with and without albuminuria. Diabetes 43:649-655, 1994
29. GILBERT RE, Cox A, Wu LL, ALLEN TJ, HULTHEN L, JERUMS G, COOPER ME: Expression of transforming growth factor-β1 and type IV collagen in the renal tubulointerstitium in experimental diabetes: Effects of angiotensin converting enzyme inhibition. Diabetes 47:414-422, 1998
30. YAMAMOTO T, NAKAMURA T, NOBLE NA, RUOSLAHTI E, BORDER VA: Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy. Proc Natl Acad Sci USA 90:1814-1818, 1993
31. GILBERT RE, BERKA-WILKINSON JL, JOHNSON DW, Cox A, SOULIS T, Wu LL, KELLY DJ, JERUMS G, POLLOCK CA, COOPER ME: Renal expression of βig-h3 (transforming growth factor-ß inducible gene-h3) in normal and diabetic rats. Kidney Int 54:1052-1062,1998
32. PARK I-S, KIYOMOTO H, ABBOUD SL, ABBOUD HE: Expression of transforming growth factor-β and type IV collagen in early streptozotocin-induced diabetes. Diabetes 46:473-480, 1997
33. RITZ E, ZEIER M, LUNDIN P: French and German nephrologists in the mid-19th century. Am J Nephrol 9:167-172, 1989
34. SEYER-HANSEN K: Renal hypertrophy in streptozotocin-diabetic rats. Clin Sci Mol Med 51:551-555, 1976
35. SEYER-HANSEN K: Renal hypertrophy in experimental diabetes. Kidney Int 23:643-646, 1983
36. RASCH R, DØRUP J: Quantitative morphology of the rat kidney during diabetes mellitus and insulin treatment. Diabetologia 40:802-809, 1997
37. RASCH R, NORGAARD JOR: Renal enlargement: Comparative autoradiographic studies of 3H-thymidine uptake in diabetic and uninephrectomised rats. Diabetologia 25:280-287, 1983
38. WISEMAN MJ, SAUNDERS AJ, KEEN H, VIBERTI G: Effect of blood glucose control on increased glomerular filtration rate and kidney size in insulin-dependent diabetes. N EnglJ Med 312:617-621,1985
39. TUTTLE KR, BRUTON JL, PERUSEK MC, LANCASTER JL, KOPP DT, DEFRONZO R A: Effect of strict glycémie control on renal hemodynamic response to amino acids and renal enlargement in insulindependent diabetes mellitus. N EnglJ Med 324:1626-1632, 1991
40. MARSHALL SM: Diabetic nephropathy and insulin-dependent diabetes mellitus, in The Diabetes Annual/11, edited by MARSHALL SM, HOME PD, RIZZA RA, Amsterdam, Eisevier Science, 1998, p 169-164
41. BAUMOARTL H-J, SIGL G, BANHOLZER P, HASLBECK M, STANDL E: On the prognosis of IDDM patients with large kidneys. Nephrol Dial Transplant 13:630-634, 1998
42. INOMATA S: Renal hypertrophy as a prognostic index for the progression of diabetic renal disease in non-insulin-dependent diabetes mellitus. J Diabetes Complications 7:28-33, 1993
43. IHM CG, LEE GS, NAST CC, ARTISHEVSKY A, GUILLERMO R, LEVIN PS, GLASSOCK RJ, ADLER SG: Early increased renal procollagen alpha 1(IV) mRNA levels in streptozotocin induced diabetes. Kidney Int 41:768-777, 1992
44. FUKUI M, NAKAMURA T, EBIHARA I, SIIIRATO I, TOMINO Y, KOIDE H: ECM gene expression and its modulation by insulin in diabetic rats. Diabetes 41:1520-1527, 1992
45. Wu K, SETTY S, MAUER SM, KILLEN P, NAGASE H, MICHAEL AF, TSILIBARY EC: Altered kidney matrix gene expression in early stages of experimental diabetes. Acta Anal 158:155-165, 1997
46. YAGAME M, KIM Y, ZHU D, SUZUKI D, EGUCHI K, NOMOTO Y, SAKAI H, GROPPOLI T, STEFFES MW, MAUER SM: Differential distribution of type IV collagen chains in patients with diabetic nephropathy in non-insulin-dependent diabetes mellitus. Nephron 70:42-48, 1995
47. FLYVBERG A, GRDNB/EK H, CHRISTIANSEN T, BAK M, NIELSEN B, VOGEL I, HILL C, LOGAN A, 0RSKOV H: The role of growth factors in the renal complications of diabetes, in The Diabetes Annual/ 11, edited by MARSHALL SM, HOME PD, RIZZA R A, Amsterdam, Elsevier Science B.V., 1998
48. BACH LA, JERUMS G: Effect of puberty on initial kidney growth and rise in kidney IGF-I in diabetic rats. Diabetes 39:557-562,1990
49. GILBERT RE, Cox A, MCNALLY PG, DZIADEK M, Wu LL, COOPER ME, JERUMS G: Increased epidermal growth factor expression in diabetes related kidney growth. Diabetologia 40:778-785, 1997
50. SHARMA K, ZIYADEH FN: Renal hypertrophy is associated with upregulation of TGF-beta 1 gene expression in diabetic BB rat and NOD mouse. Am J Physiol 267:F1094-F1101, 1994
51. SHARMA K, JIN Y, Guo J, ZIYADEH FN: Neutralization of TGF-β by anti-TGF-β antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice. Diabetes 45:522-530, 1996
52. SIIARMA K, ZIYADEH FN: Hyperglycemia and diabetic kidney disease. The case for transforming growth factor-beta as a key mediator. Diabetes 44:1139-1146, 1995
53. ZIYADEH FN, SNIPES ER, W ATANABE M, ALVAREZ RJ, GOLDFARB S, HAVERTvTP: High glucose induces cell hypertrophy and stimulates collagen gene transcription in proximal tubule. Am J Physiol 259:F704-F714, 1990
54. JONES SC, SAUNDERS HJ, Qi W, POLLOCK CA: Intermittent high glucose enhances cell growth and collagen synthesis in cultured human tubulointerstitial cells. Diabetologia 1999 (in press)
55. HOOKE DH, GEE DC, ATKINS RC: Leukocyte analysis using monoclonal antibodies in human glomerulonephritis. Kidney Int 31:964-972, 1987
56. BLEYER AJ, FUMO P, SNIPES ER, GOLDFARB S, SIMMONS DA, ZIYADEH FN: Polyol pathway mediates high glucose-induced collagen synthesis in proximal tubule. Kidney lut 45:659-666, 1994
57. HARRIS RC, BRENNER BM, SEIFTER JL: Sodium-hydrogen exchange and glucose transport in renal microvillus membrane vesicles from rats with diabetes mellitus. / Clin Invest 77:724-733, 1986
58. CARNEY L, WO.NG NLM, DIRKS JH: Acute effects of streptozotocin diabetes on rat renal function. J Lab Clin Med 93:950-961, 1979
59. ASADA T, OOAWA T, IWAI M, SHIMOMURA K, KOBAYASHI M: Recombinant insulin-like growth factor I normalizes expression of renal glucose transporters in diabetic rats. Am J Pliysiol 273:F27-F37, 1997
60. PHILLIPS AO, STEADMAN R, MORRISEY K, WILLIAMS JD: Polarity of stimulation and secretion of transforming growth factor-beta 1 by cultured proximal tubular cells. AmJPatlwl 150:1101-1111,1997
61. GREENE DA, LATTIMER SA, SIMA AAF: Sorbitol, phosphoinositides, and sodium-potassium-ATPase in the pathogenesis of diabetic complications. N Engl J Med 316:599-606, 1987
62. MORRISEY K, STEADMAN R, WILLIAMS JD, PHILLIPS AO: Renal proximal tubular cell fibronectin accumulation in response to glucose is polyol pathway dependent. Kidney Int 55:160-167,1999
63. ISHII H,TADA H, ISOGAI S: An aldose reductase inhibitor prevents glucose-induced increase in transforming growth factor-ß and protein kinase C activity in cultured mesangial cells. Diabetologia 41:362-364, 1998
64. McCALEB ML, SREDY J, MILLEN J, ACKERMAN DM, DVORNIK D: Prevention of urinary albumin excretion in 6 month streptozocindiabetic rats with the aldose reductase inhibitor Tolrestat. J Diabetes Complications 2:16-18, 1988
65. BEYER-MEARS A, MISTRY K, DIECKE FPJ, CRUZ E: Zopolrestat prevention of proteinuria, albuminuria and cataractogenesis in diabetes mellitus. Pharmacology 52:292-302, 1996
66. VLASSARA H, COIIEN JJ, MADIAS NE, HARRINGTON JT, ZUSMAN CJ, WILLIAMS ME, LEVEY AS, PEREIRA B, LAFAYETTE R, BEASLEY D: Protein glycation in the kidney: Role in diabetes and aging. Kidney Int 49:1795-1804, 1996
67. SIMM A, MUNCH G, SEIF F, SCHENK O, HEIDLAND A, RICHTER H, VAMVAKAS S, SCHINZEL R: Advanced glycation endproducts stimulate the MAP-kinase pathway in tubulus cell line LLC-PK1. FEBS Lett 410:481-484, 1997
68. THROCKMORTON DC, BROGDEN AP, MIN B, RASMUSSEN H, KASIIGARIAN M: PDGF and TGF-beta mediate collagen production by mesangial cells exposed to advanced glycosylation end products. Kidney Int 48:111-117, 1995
69. LAYTON GJ, JERUMS G: Effect of glycation of albumin on its renal clearance in normal and diabetic rats. Kidney Int 33:673-676,1988
70. SOULIS T, COOPER ME, VRANES D, BUCALA R, JERUMS G: The effects of aminoguanidine in preventing experimental diabetic nephropathy are related to duration of treatment. Kidney Int 50:627-634, 1996
71. BENDAYAN M: Immunocytochemical detection of advanced glycated end products in rat renal tissue as a function of age and diabetes. Kidney Int 54:438-447, 1998
72. GUGLIUCCI A, BENDAYAN M: Renal fate of circulating advanced glycation end products (AGE): Evidence for reabsorption and catabolism of AGE-peptides by renal proximal tubular cells. Diabetologia 39:149-160, 1996
73. MIYATA T, UEDA Y, HORIE K, NANGAKU M, TANAKA S, VAN YPERSELE DE STRIIIOU C, KUROKAWA K: Renal catabolism of advanced glycation end products: The fate of pentosidine. Kidney Int 53:416-422, 1998
74. YOUSSEF S, NGUYEN DT, SOULIS T, PANAGIOTOPOULOS S, JERUMS G, COOPER ME: Effect of diabetes and aminoguanidine therapy on renal advanced glycation endproduct binding. Kidney Int 55:907-916, 1999
75. COIIEN MP, SIIARMA K, JIN Y, HUD E, Wu VY, TOMASZEWVSKI T, ZIYADEII FN: Prevention of diabetic nephropathy in db/db mice with glycated albumin antagonists, J Clin Invest 95:2338-2345, 1995
76. ALLEN TA, CAO Z, YOUSSEF S, HULTHEN L, COOPER ME: Role of angiotensin II and bradykinin in experimental diabetic nephropathy. Diabetes 46:1612-1618, 1997
77. ANDERSON S: Role of local and systemic angiotensin in diabetic renal disease. Kidney Int 52(Suppl 63):S107-S110, 1997
78. TANK JE, MOE OW, STAR RA, HENRICH WL: Differential regulation of rat glomcrular and proximal tubular renin mRNA following uninephrectomy. Am J Physiol 270:F776-F783, 1996
79. TANK JE, HENRICH WL, MOE OW: Regulation of glomerular and proximal tubule renin mRNA by chronic changes in dietary NaCl. Am J Physiol 273:FS92-FS98, 1997
80. MOE OW, UJIIE K, STAR RA, MILLER RT, WIDELL J, ALPERN RJ, HENRICH WL: Renin expression in proximal tubule. J Clin Invest 91:774-779, 1993
81. LAI KM, LEUNG JCK, LAI KB, To WY, YEUNG VTF, LAI FM-M: Gene expression of the renin-angiotensin system in human kidney. J Hypertens 16:91-102, 1998
82. WOLF G, NEILSON EG, GOLDFARB S, ZIYADEII FN: The influence of glucose concentration on angiotensin II-induced hypertrophy of proximal tubular cells in culture. Biochem Biophys Res Commun 176:902-909, 1991
83. NORMAN J, BADIE-DESFOOLY B, NORD E, KURTZ I, SCHLOSSER J, CHAUDARI A, FINE L: EGF-induced mitogenesis in proximal tubular cells: Potentiation by anuiotensin II. Am J Physiol 253:F299-F309, 1987
84. KELLY DJ, WILKINSON-BERKA JL, ALLEN TJ, COOPER ME, SKINNER SL: A new model of diabetic nephropathy with progressive renal impairment in the transgenic (mRen-2)27 rat. Kidney Int 54:343-352, 199S
85. WOLF G, NEILSON EG: Angiotensin II as a renal growth factor. J Am Soc Nephrol 3:1531-1540, 1992
86. WOLF G, ZIYADEII FN, ZAIINER G, STAHL RAK: Angiotensin IIstimulated expression of transforming growth factor beta in renal proximal tubular cells: Attenuation after stable transfection with the c-mas oncogene. Kidney Int 48:1818-1827, 1995
87. RUIZ-ORTEGA M, EGIDO J: Angiotensin II modulates cell growthrelated events and synthesis of matrix proteins in renal interstitial fibroblasts. Kidney Int 52:1497-1510, 1997
88. ZHANG SL, FILEP JO, HOIIMAN TC, TANG SS, INGELFINGER JR, CHAN JSD: Molecular mechanisms of glucose action on angiotensinogen gene expression in rat proximal tubular cells. Kidney Int 55:454-464, 1999
89. BECKER BN, KONDO S, CHENG HF, HARRIS RC: Effect of glucose, pyruvate, and insulin on type 1 angiotensin II receptor expression in sv40-immortalized rabbit proximal tubule epithelial cells. Kidney Int 52:87-92, 1997
90. GABER L, WALTON C, BROWN S, BAKRIS G: Effects of different antihypertensive treatments on morphologic progression of diabetic nephropathy in uninephrectomized dogs. Kidney Int 46:161169, 1994
91. CORDONNIER DJ, PINEL N, BARRO C, MAYNARD C, ZAOUI P, DE HALIMI S, LIGNY BH, REZNIC Y, SIMON D, BILOUS RW: Expansion of cortical interstitium is limited by converting enzyme inhibition in type 2 diabetic patients with glomerulosclerosis. J Am Soc Nephrol 10:1253-1263, 1999
92. FUKUI M, NAKAMURA T, EBIHARA I, OSADA S, TOMISO Y, MASAKI T, GOTO K, FURUICHI Y, KOIDE H: Gene expression for endothelin and their receptors in glomeruli of diabetic rats. J Lab Clin Med 122:149-156, 1993
93. SHIN SJ, LEE YJ, LIN SR, TAN MS, LAI YH, TSAI JH: Decrease of renal endothelin 1 content and gene expression in diabetic rats with moderate hyperglycemia. Nephron 70:486-493, 1995
94. BENIGNI A, COLOSIO W, BRENA C, BRUZZI I, BERTANI T, REMUZZI G: Unselective inhibition of endothelin receptors reduces renal dysfunction in experimental diabetes. Diabetes 47:450-456, 1998
95. POULSEN PL, HANSEN KW, MOGENSEN CE: Ambulatory blood pressure in the transition from normo- to microalbuminuria: A longitudinal study in IDDM patients. Diabetes 43:1248-1253,1994
96. JOHNSON RJ, SCHREINER GF: Hypothesis: The role of acquired tubulointerstitial disease in the pathogenesis of salt-dependent hypertension. Kidney 7/1/52:1169-1179, 1997
97. JOHNSON RJ, ALPERS CE, YOSHIMURA A, LOMBARDI D, PRITZL P, SCIIWARTZ SM: Renal injury from angiotensin II-mediated hypertension. Hypertension 19:464-474, 1992
98. ALLEN TJ, COOPER ME, O'BRIEN RC, BACH LA, JACKSON B, JERUMS G: Glomerular filtration rate in the streptozocin diabetic rat: The role of exchangeable sodium, vasoactive hormones and insulin therapy. Diabetes 38:1182-1190, 1990
99. Yu HC, BURRELL LM, BLACK MJ, Wu LL, DILLEV RJ, COOPER ME, JOHNSTO.N CI: Salt induces myocardial and renal fibrosis in normotensive and hypertensive rats. Circulation 98:2621-2628,1998
100. REMUZZI G, RUGGENENTI P, BENIGNI A: Understanding the nature of renal disease progression. Kidney Int 51:2-15, 1997
101. ABBATE M, ZOJA C, CORNA D, CAPITANIO M, BERTANI T, REMUZZI G: In progressive nephropathies, overload of tubular cells with filtered proteins translates glomerular permeability dysfunction into cellular signals of interstitial inflammation. J Am Soc Nephrol 9:1213-1224, 1998
102. FIORETTO P, STEFFES MV, SUTHERLAND DER, MAUER SM: Sequential renal biopsies in insulin-dependent diabetic patients: Structural factors associated with clinical progression. Kidney Int 48:1929-1935, 1995
103. LEWIS EJ, HUNSICKER LG, BAIN RP, ROIIDE RD, FOR THE COLLABORATIVE STUDY GROUP: The effect of angiotensin-converting-enzyme inhibition on diabetic nephropaihy. N EngU Med 329:14561462, 1993
104. KASISKE B, KALIL R, MA J, LIAO M, KEANE W: Effect of antihypertensive therapy on the kidney in patients with diabetes: A metaregression analysis. Ann Intern Med 118:129-138, 1993
105. SCHRIER RW, HARRIS DC, CHAN L, SIIAPIRO JI, CARAMELO C: Tubular hypermetabolism as a factor in the progression of chronic renal failure. Am J Kidney Dis 12:243-249, 1988
106. KREISBERG JJ, VENKATACHALAM MA: Morphological factors in acute renal failure, in Acute Renal Failure, edited by BRENNER BL, New York, Churchill Livingstone, 1988, p 45-65
107. NUYTS GD, YAQOOB M, NOUWEN EJ, PATRICK AW, MCCLELLAND P, MACFARLANE IA, BELL GM, DE ERDE ME: Human urinary intestinal alkaline phosphatase as an indicator of S3-segmentspecific alterations in incipient diabetic nephropathy. Nephrol Dial Transplant 9:377-381, 1994
108. S. GILBERT RE, TSALAMANDRIS C, BACH L, PANAGIOTOPOULOS S, O'BRIEN RC, ALLEN TJ, GOODALL I, SEEMAN E, COOPER ME, MURRAY R, JERUMS G: Glycémie control and the rate of progression of early diabetic kidney disease. Kidney Int 44:855-859,1993
109. THE GISEN GROUP (GRUPPO ITALIANO DI SIUDI EPIDEMIOLOGICI IN NEFROLOGIA): Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. Lancet 349:1857-1863, 1997